185 related articles for article (PubMed ID: 26864029)
1. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
[TBL] [Abstract][Full Text] [Related]
2. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.
Linke MJ; Ashbaugh AD; Demland JA; Walzer PD
Respir Res; 2009 Feb; 10(1):10. PubMed ID: 19228388
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.
Eddens T; Elsegeiny W; Nelson MP; Horne W; Campfield BT; Steele C; Kolls JK
J Immunol; 2015 Jul; 195(1):185-93. PubMed ID: 25994969
[TBL] [Abstract][Full Text] [Related]
5. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.
Feola DJ; Garvy BA
Clin Vaccine Immunol; 2006 Feb; 13(2):193-201. PubMed ID: 16467325
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the intestinal microbial community and inferred functional capacities during the host response to Pneumocystis pneumonia.
Samuelson DR; Charles TP; de la Rua NM; Taylor CM; Blanchard EE; Luo M; Shellito JE; Welsh DA
Exp Lung Res; 2016; 42(8-10):425-439. PubMed ID: 27925857
[TBL] [Abstract][Full Text] [Related]
7. B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.
Opata MM; Ye Z; Hollifield M; Garvy BA
Infect Immun; 2013 Nov; 81(11):4252-60. PubMed ID: 24002064
[TBL] [Abstract][Full Text] [Related]
8. Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.
Dai G; Noell K; Weckbecker G; Kolls JK
mSphere; 2021 May; 6(3):. PubMed ID: 33952667
[TBL] [Abstract][Full Text] [Related]
9. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.
Nelson MP; Christmann BS; Werner JL; Metz AE; Trevor JL; Lowell CA; Steele C
J Immunol; 2011 Feb; 186(4):2372-81. PubMed ID: 21220696
[TBL] [Abstract][Full Text] [Related]
10. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.
Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A
J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544
[TBL] [Abstract][Full Text] [Related]
11. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
[No Abstract] [Full Text] [Related]
12. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
[TBL] [Abstract][Full Text] [Related]
13. Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression.
Linke M; Ashbaugh A; Demland J; Koch J; Tanaka R; Walzer P
Microb Pathog; 2006 Jan; 40(1):15-22. PubMed ID: 16321497
[TBL] [Abstract][Full Text] [Related]
14. CD4
Rapaka RR; Dai G; Zheng M; Kolls JK
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010812
[No Abstract] [Full Text] [Related]
15. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
[TBL] [Abstract][Full Text] [Related]
16. The Interaction of
Kottom TJ; Hebrink DM; Jenson PE; Nandakumar V; Wüthrich M; Wang H; Klein B; Yamasaki S; Lepenies B; Limper AH
J Immunol; 2017 May; 198(9):3515-3525. PubMed ID: 28298521
[No Abstract] [Full Text] [Related]
17. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.
Lund FE; Schuer K; Hollifield M; Randall TD; Garvy BA
J Immunol; 2003 Aug; 171(3):1423-30. PubMed ID: 12874234
[TBL] [Abstract][Full Text] [Related]
18. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
Empey KM; Hollifield M; Schuer K; Gigliotti F; Garvy BA
Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
[TBL] [Abstract][Full Text] [Related]
19. B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.
Hoyt TR; Dobrinen E; Kochetkova I; Meissner N
Infect Immun; 2015 Feb; 83(2):743-58. PubMed ID: 25452554
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.
Zheng M; Shellito JE; Marrero L; Zhong Q; Julian S; Ye P; Wallace V; Schwarzenberger P; Kolls JK
J Clin Invest; 2001 Nov; 108(10):1469-74. PubMed ID: 11714738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
